|
|
|
Insider
Information: |
Torley Helen |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
683,004 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$30,539,335 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
683,004 |
|
|
Total
Value |
$30,539,335 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-28.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP, Chief Commercial ... |
2013-10-01 |
0 |
2011-08-29 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
|
2024-02-16 |
676,744 |
2014-09-16 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Quest Diagnostics Inc |
DGX |
Director |
2021-05-25 |
6,260 |
2018-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-10 |
4 |
D |
$48.92 |
$805,663 |
D/D |
(16,469) |
601,989 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,281 |
618,458 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-12 |
4 |
D |
$48.92 |
$844,653 |
D/D |
(17,266) |
617,517 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,794 |
634,783 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-15 |
4 |
D |
$49.20 |
$339,086 |
D/D |
(6,892) |
623,717 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,092 |
630,609 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-16 |
4 |
S |
$49.26 |
$544,865 |
D/D |
(11,061) |
633,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,010 |
644,727 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
623,666 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-07 |
4 |
AS |
$45.47 |
$454,690 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-07 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
633,666 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-08 |
4 |
AS |
$43.26 |
$432,590 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-08 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
633,666 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-09 |
4 |
AS |
$42.73 |
$427,270 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-03-09 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
633,666 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-07-25 |
4 |
AS |
$42.80 |
$427,960 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-07-25 |
4 |
OE |
$13.87 |
$138,700 |
D/D |
10,000 |
633,666 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-07-26 |
4 |
AS |
$42.69 |
$426,890 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-07-26 |
4 |
OE |
$13.87 |
$138,700 |
D/D |
10,000 |
633,666 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-07-27 |
4 |
OE |
$13.87 |
$138,700 |
D/D |
10,000 |
633,666 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-07-27 |
4 |
AS |
$43.79 |
$437,900 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-08-15 |
4 |
AS |
$43.77 |
$437,680 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-08-15 |
4 |
OE |
$13.87 |
$138,700 |
D/D |
10,000 |
633,666 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-08-16 |
4 |
AS |
$43.53 |
$435,320 |
D/D |
(10,000) |
623,666 |
0 |
% |
|
HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
|
2023-08-16 |
4 |
OE |
$13.87 |
$138,700 |
D/D |
10,000 |
633,666 |
0 |
- |
|
169 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|